A key objective of the National Cervical Screening Programme (NCSP) is to reduce the incidence of cervical cancer by detecting precancerous high grade squamous intra-epithelial lesions (HSIL). Monitoring trends in HSIL detection is critical to understanding the epidemiology of cervical cancer in New Zealand and to evaluating the performance of the NCSP.
Women who have symptoms of breast cancer are sometimes referred to BreastScreen
Aotearoa (BSA) by their GP, or self refer to the programme. However, this has a
number of risks, including that the breast cancer may not be detected by a
mammogram and that there will be a delay in the diagnosis of breast cancer.
Dr Madeleine Wall, Clinical Leader, BreastScreen Aotearoa.
This overview of workforce development for BreastScreen Aotearoa (BSA) Medical Radiation Technologists (MRTs) and radiologists is part of the wider workforce initiatives for health professionals within the Ministry of Health.
The purpose of this report is to present information on 2 year interval breast cancers from the BreastScreen Aotearoa (BSA) mammographic screening programme and to compare this with published results from other services.